GLAXOSMITH - Glaxo Smithkline Consumer
Manufacturing, Marketing and Distribution of Pharmaceutical, Oral Care and Nutritional Products
| Last Trading Results | Growth & Valuation | ||
|---|---|---|---|
| Opening Price: | 4.80 | Earnings Per Share: | -- |
| Day's Low Price: | 4.35 | Price/Earning Ratio: | -- |
| Day's High Price: | 4.85 | Dividend Per Share: | -- |
| Traded Volume: | 2,360,756 | Dividend Yield: | -- |
| Number of Deals: | 74 | Shares Outstanding: | 1.2b |
| Value/Turnover: | 10.89m | Market Capitalization: | 5.20b |
GLAXOSMITH Stock Market Performance
| 1WK | 4WK | 3MO | 6MO | 1YR | YTD |
|---|---|---|---|---|---|
| -4.40% | -38.73% | -9.38% | -17.14% | -57.35% | -28.69% |
The current share price of Glaxo Smithkline Consumer (GLAXOSMITH) is NGN 4.35. The GLAXOSMITH stock closed its last trading day (Tuesday, July 14, 2020) at 4.35 NGN per share on the Nigerian Stock Exchange, recording a 9.38% drop from its previous closing price of 4.80 NGN. GLAXOSMITH began the year with a share price of 6.10 NGN but has since lost 28.69% off that price valuation, ranking it 144th on the NSE in terms of year-to-date performance. Shareholders' worries are further compounded by the fact that GLAXOSMITH has lost 38.73% of the stock's value from June 16 to date. The table below details the last 10 trading days of activity of Glaxo Smithkline Consumer on the Nigerian Stock Exchange.
| Date | Volume | Close | Change | Change% |
|---|---|---|---|---|
| 2020-07-14 | 2,360,756 | 4.35 | -0.45 | 9.38% |
| 2020-07-13 | 955,030 | 4.80 | -- | -- |
| 2020-07-10 | 1,566,645 | 4.80 | +0.20 | 4.35% |
| 2020-07-09 | 3,710,833 | 4.60 | -- | -- |
| 2020-07-08 | 1,672,631 | 4.60 | +0.05 | 1.10% |
| 2020-07-07 | 1,999,209 | 4.55 | -0.40 | 8.08% |
| 2020-07-06 | 262,381 | 4.95 | -- | -- |
| 2020-07-03 | 335,839 | 4.95 | -- | -- |
| 2020-07-02 | 909,150 | 4.95 | -0.55 | 10.00% |
| 2020-07-01 | 463,545 | 5.50 | -- | -- |
Profile of Glaxo Smithkline Consumer
Glaxo Smithkline Consumer operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
| Factsheet of Glaxo Smithkline Consumer | |
|---|---|
| Sector: Health Care | Industry: -- |
| Address: 1, Industrial Avenue, Ilupeju Lagos | |
| Telephone: 2711000 | |
| Email: customercare-ph-nigeria@gsk.com | Website: www.gsk.com/ng |
GLAXOSMITH Industrial Market Competitors
Glaxo Smithkline Consumer, issuers of the GLAXOSMITH stock on the Nigerian Stock Exchange, have a number of market competitors who are also engaged in the Health Care sector. The table below gives you an overview of the market standing of the top nine by year-to-date performance.
| Code | Name | Mkt. Cap. | L. Price | YearTD |
|---|---|---|---|---|
| NEIMETH | Neimeth International Pharma | 2.85b | 1.50 | +141.9% |
| MAYBAKER | May & Baker Nigeria | 4.80b | 2.78 | +44.0% |
| EKOCORP | Ekocorp Plc | 2.99b | 6.00 | +41.2% |
| MORISON | Morison Industries | 593.50m | 0.60 | +20.0% |
| UNIONDAC | UNIONDAC | 888.28m | 0.25 | +13.6% |
| NIG-GERMAN | Nigeria-German Chemicals | 556.71m | 3.62 | +0.00% |
| EVANSMED | Evans Medical Plc | 366.17m | 0.50 | +0.00% |
| PHARMDEKO | Pharma-Deko Plc | 325.23m | 1.50 | +0.00% |
| FIDSON | Fidson Healthcare | 5.95b | 2.85 | -8.06% |